ARCHIVES

Final Results from CLEOPATRA Phase III Trial Show Perjeta Increased OS 15.7 Months

This article is from The Cancer Letter archive.

Vol. 37 No. 9 | September 26, 2014

Download PDF Visit The Full Archive

Related Articles

Cancer Center Planning Grants Recompetition Approved By Advisors

June 10, 1994

Cigarette Smoking increases Among Youth, Annual Report Finds

January 12, 1996

In Brief: NIH Alumni Assn. Formed; Jenney Named Kans. Vice Chancellor; Bloomfield To Move To RPMI

June 9, 1989

“Recalcitrant” Cancers? Committee Rewrite Of Pancreatic Bill Raises New Questions

September 14, 2012

Letters From Ovarian Cancer Survivors Shed Light On Their Psychological Distress

October 31, 2003

FDA Approves Femara As First-Line Treatment For Advanced Breast Cancer.

January 26, 2001